Can we design a better anti-cytokine therapy?

Marina S Drutskaya1,2, Grigory A Efimov1,3, Andrei A Kruglov1,2,4

  • 1Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.

Related Concept Videos